abstract |
Provided are methods and compositions for treating cancer. A pharmaceutical composition comprising a combination of a 17α-hydroxylase / 17,20-lyase inhibitor such as abiraterone acetate (I) and an additional therapeutic agent such as an antitumor drug or a steroid. [Selection figure] None |